In The News Posted April 22, 2022 Share Posted April 22, 2022 A Terran avançará no desenvolvimento de dois tratamentos de SNC de Fase 3 da Sanofi A transação inclui direitos mundiais exclusivos de desenvolvimento e comercialização em todas as áreas de uso NOVA YORK, 21 de abril de 2022 /PRNewswire/ -- A Terran Biosciences, Inc. ("Terran"), uma...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now